Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects

Journal of Allergy and Clinical Immunology

Volumn 142, Issue 6, 2018, Pages 1932-1946

  Schwab, Charlotte ^a   Gabrysch, Annemarie ^a   Olbrich, Peter ^b   Patiño, Virginia ^c   Warnatz, Klaus ^a   Wolff, Daniel ^d   Hoshino, Akihiro ^e   Kobayashi, Masao ^f   Imai, Kohsuke ^e   Takagi, Masatoshi ^e   Dybedal, Ingunn ^g   Haddock, Jamanda A ^h   Sansom, David M ⁱ   Lucena, Jose M ^b   Seidl, Maximilian ^a   Schmitt Graeff, Annette ^a   Reiser, Veronika ^a,j   Emmerich, Florian ^a   Frede, Natalie ^a   Bulashevska, Alla ^a   Salzer, Ulrich ^a   Schubert, Desirée ^a,k   Hayakawa, Seiichi ^f   Okada, Satoshi ^f   Kanariou, Maria ^l   Kucuk, Zeynep Yesim ^m   Chapdelaine, Hugo ⁿ   Petruzelkova, Lenka ^o   Sumnik, Zdenek ^o   Sediva, Anna ^o   Slatter, Mary ^p   Arkwright, Peter D ^q   Cant, Andrew ^p   Lorenz, Hanns Martin ^r   Giese, Thomas ^s   Lougaris, Vassilios ^t   Plebani, Alessandro ^t   Price, Christina ^u   Sullivan, Kathleen E ^v   Moutschen, Michel ^w   Litzman, Jiri ^x,y   Freiberger, Tomas ^x,z   van de Veerdonk, Frank L ^aa   Recher, Mike ^ab   Albert, Michael H ^ac   Hauck, Fabian ^ac   Seneviratne, Suranjith ^h   Pachlopnik Schmid, Jana ^ad   Kolios, Antonios ^ae   Unglik, Gary ^af   Klemann, Christian ^a,aw   Speckmann, Carsten ^a   Ehl, Stephan ^a   Leichtner, Alan ^ag   Blumberg, Richard ^ah   Franke, Andre ^ai   Snapper, Scott ^aj   Zeissig, Sebastian ^ah,ak,al   Cunningham Rundles, Charlotte ^am   Giulino Roth, Lisa ^an   Elemento, Olivier ^an   Dückers, Gregor ^ao   Niehues, Tim ^ao   Fronkova, Eva ^o   Kanderová, Veronika ^o   Platt, Craig D ^aj   Chou, Janet ^aj   Chatila, Talal A ^aj   Geha, Raif ^aj   McDermott, Elizabeth ^ap   Bunn, Su ^aq   Kurzai, Monika ^ar   Schulz, Ansgar ^as   Alsina, Laia ^at   Casals, Ferran ^au   Deyà Martinez, Angela ^at   Hambleton, Sophie ^p   Kanegane, Hirokazu ^e   Taskén, Kjetil ^av   Neth, Olaf ^b   Grimbacher, Bodo ^a,h   more..

^a UNIVERSITY OF FREIBURG   (Germany)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c American Insurance   (Uruguay)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f HIROSHIMA UNIVERSITY   (Japan)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ ROYAL FREE HOSPITAL   (United Kingdom)

^j UNIVERSITY OF FREIBURG   (Germany)

^k UNIVERSITY OF FREIBURG   (Germany)

^l AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^m CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁿ CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^o UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^p NEWCASTLE UNIVERSITY   (United Kingdom)

^q UNIVERSITY OF MANCHESTER   (United Kingdom)

^r UNIVERSITY OF HEIDELBERG   (Germany)

^s UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^t UNIVERSITY OF BRESCIA   (Italy)

^u YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v UNIVERSITY OF PENNSYLVANIA   (United States)

^w UNIVERSITY OF LIÈGE   (Belgium)

^x MASARYK UNIVERSITY   (Czech Republic)

^y ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^z CENTRE FOR CARDIOVASCULAR SURGERY AND TRANSPLANTATION   (Czech Republic)

^aa RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^ab UNIVERSITY HOSPITAL BASEL   (Switzerland)

^ac LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^ad UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^ae UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^af ROYAL MELBOURNE HOSPITAL   (Australia)

^ag HARVARD MEDICAL SCHOOL   (United States)

^ah BRIGHAM AND WOMEN S HOSPITAL   (United States)

^ai UNIVERSITY OF KIEL   (Germany)

^aj BOSTON CHILDREN S HOSPITAL   (United States)

^ak UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^al UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^am MOUNT SINAI HOSPITAL   (United States)

^an WEILL CORNELL MEDICAL COLLEGE   (United States)

^ao HELIOS Children's Hospital   (Germany)

^ap NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^aq Newcastle Upon Tyne Hospitals NHS Foundation Trust   (United Kingdom)

^ar JENA UNIVERSITY HOSPITAL   (Germany)

^as UNIVERSITY HOSPITAL ULM   (Germany)

^at Institut de Recerca Pediàtrica Hospital Sant Joan de Déu   (Spain)

^au UNIVERSITAT POMPEU FABRA   (Spain)

^av UNIVERSITY OF OSLO   (Norway)

^aw HANNOVER MEDICAL SCHOOL   (Germany)

more..

Author keywords

abatacept; autoimmunity; common variable immunodeficiency; Cytotoxic T lymphocyte antigen 4; hematopoietic stem cell transplantation; hypogammaglobulinemia; immune dysregulation; primary immunodeficiency; sirolimus

Indexed keywords

ABATACEPT; BELATACEPT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR; METHYLPREDNISOLONE; PREDNISOLONE; RAPAMYCIN; RITUXIMAB; TRANSCRIPTION FACTOR FOXP3; CTLA4 PROTEIN, HUMAN;

ACUTE LIVER FAILURE; ACUTE PANCREATITIS; ADDISON DISEASE; ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; ALLERGIC ENCEPHALITIS; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALOPECIA; AMNESIA; ANIMAL CELL; APHASIA; ARTERY THROMBOSIS; ARTHRITIS; ARTICLE; ASPERGILLOSIS; ASTHMA; ATAXIA; ATOPIC DERMATITIS; ATROPHIC GASTRITIS; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; B LYMPHOCYTE SUBPOPULATION; BLADDER DYSFUNCTION; BRAIN HERNIA; BRAIN ISCHEMIA; BRONCHIECTASIS; BRONCHIOLITIS; BRONCHITIS; BURKITT LYMPHOMA; CANDIDIASIS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELIAC DISEASE; CHILD; CHOREA; CHROMOSOME 2; CLINICAL FEATURE; COGNITIVE DEFECT; COHORT ANALYSIS; COLON CANCER; COMMON VARIABLE IMMUNODEFICIENCY; CROHN DISEASE; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; CYTOTOXIC T LYMPHOCYTE; DEVELOPMENTAL DELAY; DIABETIC KETOACIDOSIS; DIARRHEA; DIFFUSE LARGE B CELL LYMPHOMA; DRUG WITHDRAWAL; ECZEMA; ELEVATED BLOOD PRESSURE; ENTEROPATHY; EPSTEIN BARR VIRUS INFECTION; ERYTHEMA NODOSUM; FACIAL NERVE PARALYSIS; FATALITY; FEMALE; FEVER; FIBROSING ALVEOLITIS; GASTRITIS; GENE DELETION; GENE INSERTION; GERMLINE MUTATION; GLIOSIS; GRAFT VERSUS HOST REACTION; GROWTH RETARDATION; HAEMOPHILUS INFLUENZAE; HEADACHE; HEMANGIOFIBROMA; HEMIPARESIS; HEMIPLEGIA; HEMOPHAGOCYTIC SYNDROME; HEPATOMEGALY; HETEROZYGOTE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HYDROCEPHALUS; HYPOTHYROIDISM; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFANTILE SPASM; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL LUNG DISEASE; IPEX SYNDROME; LIVER CIRRHOSIS; LUNG EMPHYSEMA; LUNG INJURY; LUNG NODULE; LYMPHADENITIS; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; LYMPHOCYTOPENIA; LYMPHOMATOID GRANULOMATOSIS; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MENTAL DEFICIENCY; MENTAL INSTABILITY; MIDDLE AGED; MISSENSE MUTATION; MORTALITY RATE; MULTIPLE ORGAN FAILURE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER T CELL; NAUSEA; NEUTROPENIA; NIGHT SWEAT; NONHODGKIN LYMPHOMA; NONHUMAN; NONSENSE MUTATION; ONSET AGE; OPTIC NEURITIS; OTITIS MEDIA; PANCREATIC INSUFFICIENCY; PARAPLEGIA; PARESIS; PAROTID ENLARGEMENT; PENETRANCE; PERNICIOUS ANEMIA; PHENOTYPE; PNEUMONIA; PRESCHOOL CHILD; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PSORIASIS; PSORIATIC ARTHRITIS; PURE RED CELL ANEMIA; RECURRENT INFECTION; REGULATORY T LYMPHOCYTE; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; RETINA TEAR; RHEUMATOID ARTHRITIS; SALMONELLA ENTERICA SEROVAR ENTERITIDIS; SCHOOL CHILD; SEIZURE; SEPSIS; SINUSITIS; SPLENOMEGALY; STAPHYLOCOCCUS AUREUS; STIFF MAN SYNDROME; STOMACH ADENOCARCINOMA; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTOPENIA; THYROID DISEASE; TONIC CLONIC SEIZURE; TOTAL PARENTERAL NUTRITION; TOTAL STOMACH RESECTION; TREATMENT OUTCOME; TUBEROUS SCLEROSIS; VERY ELDERLY; VIRUS LOAD; VIRUS REACTIVATION; VITILIGO; VOMITING; WOUND HEALING; YOUNG ADULT; DIAGNOSTIC IMAGING; GENETICS; IMMUNE DEFICIENCY; MUTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CTLA-4 ANTIGEN; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; YOUNG ADULT;

EID: 85048319931     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2018.02.055     Document Type: Article

References (42)

1. Kuehn, H.S., Ouyang, W., Lo, B., Deenick, E.K., Niemela, J.E., Avery, D.T., et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 345 (2014), 1623–1627.
2. Schubert, D., Bode, C., Kenefeck, R., Hou, T.Z., Wing, J.B., Kennedy, A., et al. Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nat Med 20 (2014), 1410–1416.
3. Zeissig, S., Petersen, B.S., Tomczak, M., Melum, E., Huc-Claustre, E., Dougan, S.K., et al. Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4. Gut 64 (2015), 1889–1897.
4. Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192 (2000), 303–310.
5. Read, S., Malmstrom, V., Powrie, F., Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192 (2000), 295–302.
6. Hori, S., Nomura, T., Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003), 1057–1061.
7. Friedline, R.H., Brown, D.S., Nguyen, H., Kornfeld, H., Lee, J., Zhang, Y., et al. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med 206 (2009), 421–434.
8. Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322 (2008), 271–275.
9. Walker, L.S., Treg and CTLA-4: two intertwining pathways to immune tolerance. J Autoimmun 45 (2013), 49–57.
10. Collins, A.V., Brodie, D.W., Gilbert, R.J., Iaboni, A., Manso-Sancho, R., Walse, B., et al. The interaction properties of costimulatory molecules revisited. Immunity 17 (2002), 201–210.
11. Bour-Jordan, H., Bluestone, J.A., Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol Rev 229 (2009), 41–66.
12. Walker, L.S., Sansom, D.M., The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat Rev Immunol 11 (2011), 852–863.
13. Qureshi, O.S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E.M., et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332 (2011), 600–603.
14. Schwartz, J.C., Zhang, X., Fedorov, A.A., Nathenson, S.G., Almo, S.C., Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 410 (2001), 604–608.
15. Slatter, M.A., Engelhardt, K.R., Burroughs, L.M., Arkwright, P.D., Nademi, Z., Skoda-Smith, S., et al. Hematopoietic stem cell transplantation for CTLA4 deficiency. J Allergy Clin Immunol 138 (2016), 615–619.e1.
16. Hayakawa, S., Okada, S., Tsumura, M., Sakata, S., Ueno, Y., Imai, K., et al. A patient with CTLA-4 haploinsufficiency presenting gastric cancer. J Clin Immunol 36 (2016), 28–32.
17. Hou, T.Z., Olbrich, P., Soto, J.M.L., Sanchez, B., Moreno, P.S., Borte, S., et al. Study of an extended family with CTLA-4 deficiency suggests a CD28/CTLA-4 independent mechanism responsible for differences in disease manifestations and severity. Clin Immunol 188 (2018), 94–102.
18. Kucuk, Z.Y., Charbonnier, L.M., McMasters, R.L., Chatila, T., Bleesing, J.J., CTLA-4 haploinsufficiency in a patient with an autoimmune lymphoproliferative disorder. J Allergy Clin Immunol 140 (2017), 862–864.e4.
19. Navarini, A.A., Hruz, P., Berger, C.T., Hou, T.Z., Schwab, C., Gabrysch, A., et al. Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis. J Allergy Clin Immunol 139 (2017), 1043–1046.e5.
20. European Society for Immunodeficiencies. New clinical diagnosis criteria for the ESID Registry. Available at: https://esid.org/Working-Parties/Registry/Diagnosis-criteria. Accessed May 16, 2018.
21. Picard, C., Al-Herz, W., Bousfiha, A., Casanova, J.L., Chatila, T., Conley, M.E., et al. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol 35 (2015), 696–726.
22. Hou, T.Z., Verma, N., Wanders, J., Kennedy, A., Soskic, B., Janman, D., et al. Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations. Blood 129 (2017), 1458–1468.
23. Lo, B., Zhang, K., Lu, W., Zheng, L., Zhang, Q., Kanellopoulou, C., et al. Autoimmune disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science 349 (2015), 436–440.
24. Oliveira, J.B., Bleesing, J.J., Dianzani, U., Fleisher, T.A., Jaffe, E.S., Lenardo, M.J., et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 116 (2010), e35–e40.
25. Barzaghi, F., Passerini, L., Bacchetta, R., Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol, 3, 2012, 211.
26. Charbonnier, L.M., Janssen, E., Chou, J., Ohsumi, T.K., Keles, S., Hsu, J.T., et al. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. J Allergy Clin Immunol 135 (2015), 217–227.
27. Flanagan, S.E., Haapaniemi, E., Russell, M.A., Caswell, R., Lango Allen, H., De Franco, E., et al. Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nat Genet 46 (2014), 812–814.
28. Fontenot, J.D., Gavin, M.A., Rudensky, A.Y., Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003), 330–336.
29. Gamez-Diaz, L., August, D., Stepensky, P., Revel-Vilk, S., Seidel, M.G., Noriko, M., et al. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency. J Allergy Clin Immunol 137 (2016), 223–230.
30. Lopez-Herrera, G., Tampella, G., Pan-Hammarstrom, Q., Herholz, P., Trujillo-Vargas, C.M., Phadwal, K., et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet 90 (2012), 986–1001.
31. Milner, J.D., Vogel, T.P., Forbes, L., Ma, C.A., Stray-Pedersen, A., Niemela, J.E., et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 125 (2015), 591–599.
32. Ochs, H.D., Gambineri, E., Torgerson, T.R., IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res 38 (2007), 112–121.
33. Serwas, N.K., Kansu, A., Santos-Valente, E., Kuloglu, Z., Demir, A., Yaman, A., et al. Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype. Inflamm Bowel Dis 21 (2015), 40–47.
34. Seidel, M.G., Hirschmugl, T., Gamez-Diaz, L., Schwinger, W., Serwas, N., Deutschmann, A., et al. Long-term remission after allogeneic hematopoietic stem cell transplantation in LPS-responsive beige-like anchor (LRBA) deficiency. J Allergy Clin Immunol 135 (2015), 1384–1390 e1-8.
35. Revel-Vilk, S., Fischer, U., Keller, B., Nabhani, S., Gamez-Diaz, L., Rensing-Ehl, A., et al. Autoimmune lymphoproliferative syndrome-like disease in patients with LRBA mutation. Clin Immunol 159 (2015), 84–92.
36. Schreiner, F., Plamper, M., Dueker, G., Schoenberger, S., Gamez-Diaz, L., Grimbacher, B., et al. Infancy-onset T1DM, short stature, and severe immunodysregulation in two siblings with a homozygous LRBA mutation. J Clin Endocrinol Metab 101 (2016), 898–904.
37. Alangari, A., Alsultan, A., Adly, N., Massaad, M.J., Kiani, I.S., Aljebreen, A., et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J Allergy Clin Immunol 130 (2012), 481–488.e2.
38. Alkhairy, O.K., Abolhassani, H., Rezaei, N., Fang, M., Andersen, K.K., Chavoshzadeh, Z., et al. Spectrum of phenotypes associated with mutations in LRBA. J Clin Immunol 36 (2016), 33–45.
39. Burns, S.O., Zenner, H.L., Plagnol, V., Curtis, J., Mok, K., Eisenhut, M., et al. LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemia. J Allergy Clin Immunol 130 (2012), 1428–1432.
40. Levy, E., Stolzenberg, M.C., Bruneau, J., Breton, S., Neven, B., Sauvion, S., et al. LRBA deficiency with autoimmunity and early onset chronic erosive polyarthritis. Clin Immunol 168 (2016), 88–93.
41. Sari, S., Dogu, F., Hwa, V., Haskologlu, S., Dauber, A., Rosenfeld, R., et al. A successful HSCT in a girl with novel LRBA mutation with refractory celiac disease. J Clin Immunol 36 (2016), 8–11.
42. Tesi, B., Priftakis, P., Lindgren, F., Chiang, S.C., Kartalis, N., Lofstedt, A., et al. Successful hematopoietic stem cell transplantation in a patient with LPS-responsive beige-like anchor (LRBA) gene mutation. J Clin Immunol 36 (2016), 480–489.